Clinical Trial: Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309029) titled 'Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR' on Nov. 24.

Brief Summary: The goal of this clinical trial is to evaluate the feasibility, effectiveness, and safety of pre-emptive left atrial veno-arterial extracorporeal membrane oxygenation (LAVA-ECMO) in patients undergoing complex and high-risk transcatheter aortic valve replacement (TAVR). These patients include adults with severe aortic stenosis who are hemodynamically unstable or at risk of instability due to anatomical complexity. The main questions it aims to answer are:

1. Does pre-emptive LAVA-ECMO reduce the incidence of in-hospital death, intraprocedural cardiac arres...